- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of KDM6A confers drug resistance in acute myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-15
DOI
10.1038/s41375-019-0497-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors
- (2018) Jaclyn Andricovich et al. CANCER CELL
- Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients
- (2018) Philipp A. Greif et al. CLINICAL CANCER RESEARCH
- MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes
- (2018) Shilpa S. Dhar et al. MOLECULAR CELL
- UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs
- (2018) Malgorzata Gozdecka et al. NATURE GENETICS
- UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma
- (2018) Xiaoxi Li et al. Nature Communications
- Histone H3 lysine 4 methyltransferase KMT2D
- (2017) Eugene Froimchuk et al. GENE
- Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2
- (2017) Lian Dee Ler et al. Science Translational Medicine
- Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome
- (2017) Patricia Macanas-Pirard et al. Oncotarget
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia
- (2016) Jeong-Hyun Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma
- (2016) C. Pawlyn et al. CLINICAL CANCER RESEARCH
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations
- (2016) Jean-François Spinella et al. Oncotarget
- Genomic Profiling of Advanced-Stage, Metaplastic Breast Carcinoma by Next-Generation Sequencing Reveals Frequent, Targetable Genomic Abnormalities and Potential New Treatment Options
- (2015) Jeffrey S. Ross et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- IBS: an illustrator for the presentation and visualization of biological sequences: Fig. 1.
- (2015) Wenzhong Liu et al. BIOINFORMATICS
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets
- (2015) Marçal Pastor-Anglada et al. Frontiers in Pharmacology
- An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging
- (2015) Binje Vick et al. PLoS One
- Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells
- (2014) Toshiyuki Matsunaga et al. ANTI-CANCER DRUGS
- Concurrent Alterations in TERT, KDM6A, and the BRCA Pathway in Bladder Cancer
- (2014) M. L. Nickerson et al. CLINICAL CANCER RESEARCH
- Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol
- (2014) N. Bolli et al. HAEMATOLOGICA
- SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study
- (2014) Haixia Wan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
- (2014) Panagiotis Ntziachristos et al. NATURE
- The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
- (2014) Robert Huether et al. Nature Communications
- The MLL3/MLL4 Branches of the COMPASS Family Function as Major Histone H3K4 Monomethylases at Enhancers
- (2013) D. Hu et al. MOLECULAR AND CELLULAR BIOLOGY
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity
- (2012) C. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
- (2010) Maria E. Figueroa et al. CANCER CELL
- Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes
- (2010) Diego Pasini et al. NUCLEIC ACIDS RESEARCH
- Histone H3K27ac separates active from poised enhancers and predicts developmental state
- (2010) M. P. Creyghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
- (2009) Gijs van Haaften et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More